Penumbra, Inc. (NYSE:PEN) Receives Average Recommendation of “Moderate Buy” from Brokerages

Shares of Penumbra, Inc. (NYSE:PEN) have been assigned an average recommendation of “Moderate Buy” from the sixteen ratings firms that are currently covering the firm, Marketbeat reports. Three research analysts have rated the stock with a hold recommendation, twelve have given a buy recommendation and one has given a strong buy recommendation to the company. The average 12 month price target among brokers that have issued a report on the stock in the last year is $292.64.

A number of equities research analysts have weighed in on the stock. StockNews.com raised shares of Penumbra from a “hold” rating to a “buy” rating in a report on Thursday. BTIG Research boosted their target price on shares of Penumbra from $232.00 to $270.00 and gave the stock a “buy” rating in a report on Tuesday, November 26th. Oppenheimer assumed coverage on shares of Penumbra in a report on Tuesday, December 17th. They set an “outperform” rating and a $275.00 target price on the stock. Canaccord Genuity Group boosted their target price on shares of Penumbra from $323.00 to $340.00 and gave the stock a “buy” rating in a report on Wednesday. Finally, UBS Group boosted their target price on shares of Penumbra from $305.00 to $320.00 and gave the stock a “buy” rating in a report on Wednesday.

Insider Activity at Penumbra

In related news, EVP Johanna Roberts sold 600 shares of the business’s stock in a transaction on Monday, December 2nd. The shares were sold at an average price of $244.49, for a total transaction of $146,694.00. Following the transaction, the executive vice president now owns 63,444 shares in the company, valued at $15,511,423.56. The trade was a 0.94 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CAO Lambert Shiu sold 654 shares of the business’s stock in a transaction on Monday, December 2nd. The shares were sold at an average price of $243.01, for a total transaction of $158,928.54. Following the transaction, the chief accounting officer now owns 20,028 shares in the company, valued at $4,867,004.28. The trade was a 3.16 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 18,219 shares of company stock worth $4,426,439 in the last quarter. Company insiders own 5.00% of the company’s stock.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the business. True Wealth Design LLC acquired a new position in Penumbra during the third quarter worth $26,000. GAMMA Investing LLC raised its holdings in Penumbra by 111.1% during the third quarter. GAMMA Investing LLC now owns 171 shares of the company’s stock worth $33,000 after buying an additional 90 shares during the last quarter. UMB Bank n.a. grew its stake in shares of Penumbra by 57.4% in the 4th quarter. UMB Bank n.a. now owns 192 shares of the company’s stock worth $46,000 after acquiring an additional 70 shares in the last quarter. Hurley Capital LLC bought a new stake in shares of Penumbra in the 4th quarter worth $56,000. Finally, Huntington National Bank grew its stake in shares of Penumbra by 138.7% in the 4th quarter. Huntington National Bank now owns 265 shares of the company’s stock worth $63,000 after acquiring an additional 154 shares in the last quarter. Institutional investors and hedge funds own 88.88% of the company’s stock.

Penumbra Trading Down 0.3 %

Shares of Penumbra stock opened at $302.82 on Friday. The firm has a market capitalization of $11.62 billion, a PE ratio of 890.64, a price-to-earnings-growth ratio of 1.99 and a beta of 0.53. The company has a current ratio of 5.82, a quick ratio of 3.25 and a debt-to-equity ratio of 0.02. The firm’s 50 day moving average is $257.15 and its 200 day moving average is $226.51. Penumbra has a 1 year low of $148.00 and a 1 year high of $310.00.

Penumbra (NYSE:PEN) last announced its quarterly earnings results on Tuesday, February 18th. The company reported $0.97 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.88 by $0.09. The company had revenue of $315.52 million for the quarter, compared to analyst estimates of $311.63 million. Penumbra had a net margin of 1.17% and a return on equity of 9.73%. Equities research analysts forecast that Penumbra will post 3.86 earnings per share for the current fiscal year.

Penumbra Company Profile

Penumbra, Inc, together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX.